◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › DRREDDY › Free Cash Flow

Dr. Reddy's Laboratories Limited (DRREDDY) Free Cash Flow 2022–TTM

DATA UPDATED 2026-11-02

Dr. Reddy's Laboratories Limited annual free cash flow for fiscal TTM was ₹4.7 billion, a decrease of 74.1% from ₹18.3 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

DRREDDY Annual Free Cash Flow

Free Cash Flow (annual)TTM → 2026-09-302026-03-312025-03-312024-03-312023-03-312022-03-31
Free Cash Flow₹4.7B₹18.3B₹12.0B₹18.0B₹40.0B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DRREDDY Quarterly Free Cash Flow

Free Cash Flow (quarterly)2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Free Cash Flow₹959M(₹4.6B)₹4.8B₹3.6B₹5.4B——

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Free Cash Flow at Comparable Companies

More DRREDDY metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS

All DRREDDY financial statements → Interactive DRREDDY charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.